Company Prosensa Holding NV
Equities
NL0010524443
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | BioMarin Pharmaceutical : S&P 500 ticks up to record on central bank bets | RE |
2014 | BioMarin Pharmaceutical : to buy Prosensa in $840 million deal | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,141,379 | 352,768 ( 0.9761 %) | 0 | 0.9761 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- Stock
- Company Prosensa Holding NV